Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
DaVita Community
NYSE:DVA Community
1
Narratives
written by author
0
Comments
on narratives written by author
34
Fair Values set
on narratives written by author
Create a narrative
DaVita
Latest
Undervalued
Overvalued
Community Investing Ideas
DaVita
AN
AnalystConsensusTarget
Consensus Narrative from 9 Analysts
Medicare Shifts And Patient Demographics Will Reshape Kidney Care
Key Takeaways Demographic trends and strategic investments in care models position DaVita for long-term growth and margin expansion in the kidney care market. Operational resilience, digitalization, and disciplined capital allocation support margin preservation and incremental shareholder value amid regulatory and industry shifts.
View narrative
US$163.89
FV
15.9% undervalued
intrinsic discount
4.38%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
17
users have followed this narrative
5 days ago
author updated this narrative
Your Valuation for
DVA
DVA
DaVita
Your Fair Value
US$
Current Price
US$137.84
20.9% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
0
16b
2015
2018
2021
2024
2025
2027
2030
Revenue US$16.1b
Earnings US$1.1b
Advanced
Set Fair Value